Literature DB >> 22785360

Rotavirus infection of human cholangiocytes parallels the murine model of biliary atresia.

Abigail Coots1, Bryan Donnelly, Sujit K Mohanty, Monica McNeal, Karol Sestak, Greg Tiao.   

Abstract

INTRODUCTION: Biliary atresia (BA) is the leading indication for liver transplantation in the pediatric population. The murine model of BA supports a viral etiology, because infection of neonatal mice with rhesus rotavirus (RRV) results in biliary obstruction. Viral infection targets the biliary epithelium and development of the model is viral strain dependent. No study has yet determined whether human cholangiocytes are also susceptible to rotaviral infection. We established an in vitro human model using an immortalized human cholangiocyte cell line and primary human cholangiocytes obtained from explanted livers to determine human cholangiocyte susceptibility to rotavirus infection.
METHODS: Replication and binding assays were performed on immortalized mouse (mCL) and human (H69) cells using six different strains of rotavirus. Primary human cholangiocytes were isolated from cadaveric livers, characterized in culture, and infected with RRV, which causes BA in mice, and another simian strain, TUCH, which does not cause BA in mice.
RESULTS: Immortalized mouse and human cholangiocytes demonstrated similar patterns of infectivity and binding with different strains of rotavirus. Both cell lines produced a significantly higher viral yield with RRV infection than with the other strains tested. In primary human cholangiocytes, which maintained their epithelial characteristics, as demonstrated by cytokeratin staining, RRV replicated to a yield 1000-fold higher than TUCH.
CONCLUSIONS: Both immortalized and primary human cholangiocytes are susceptible to RRV infection in a fashion similar to murine cholangiocytes. These novel findings suggest rotavirus infection could have a potential role in the pathogenesis of human BA.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22785360      PMCID: PMC3438350          DOI: 10.1016/j.jss.2012.05.082

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  20 in total

1.  Detection of group C rotavirus in infants with extrahepatic biliary atresia.

Authors:  M Riepenhoff-Talty; V Gouvea; M J Evans; L Svensson; E Hoffenberg; R J Sokol; I Uhnoo; S J Greenberg; K Schäkel; G Zhaori; J Fitzgerald; S Chong; M el-Yousef; A Nemeth; M Brown; D Piccoli; J Hyams; D Ruffin; T Rossi
Journal:  J Infect Dis       Date:  1996-07       Impact factor: 5.226

Review 2.  Etiopathogenesis of biliary atresia.

Authors:  R J Sokol; C Mack
Journal:  Semin Liver Dis       Date:  2001-11       Impact factor: 6.115

3.  Biliary atresia and reovirus type 3 infection.

Authors:  R Morecki; J H Glaser; S Cho; W F Balistreri; M S Horwitz
Journal:  N Engl J Med       Date:  1984-06-14       Impact factor: 91.245

4.  Detection of reovirus type 3 in the porta hepatis of an infant with extrahepatic biliary atresia: ultrastructural and immunocytochemical study.

Authors:  R Morecki; J H Glaser; A B Johnson; Y Kress
Journal:  Hepatology       Date:  1984 Nov-Dec       Impact factor: 17.425

5.  Role of reovirus type 3 in persistent infantile cholestasis.

Authors:  J H Glaser; W F Balistreri; R Morecki
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

6.  Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia.

Authors:  Pranavkumar Shivakumar; Kathleen M Campbell; Gregg E Sabla; Alexander Miethke; Greg Tiao; Monica M McNeal; Richard L Ward; Jorge A Bezerra
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

7.  Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination.

Authors:  M M McNeal; R L Broome; R L Ward
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

8.  Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice.

Authors:  M Riepenhoff-Talty; K Schaekel; H F Clark; W Mueller; I Uhnoo; T Rossi; J Fisher; P L Ogra
Journal:  Pediatr Res       Date:  1993-04       Impact factor: 3.756

9.  Rotavirus antigenaemia and viraemia: a common event?

Authors:  Sarah E Blutt; Carl D Kirkwood; Viviana Parreño; Kelly L Warfield; Max Ciarlet; Mary K Estes; Karin Bok; Ruth F Bishop; Margaret E Conner
Journal:  Lancet       Date:  2003-11-01       Impact factor: 79.321

10.  The viral association of neonatal cholestasis in Sweden: a possible link between cytomegalovirus infection and extrahepatic biliary atresia.

Authors:  B Fischler; A Ehrnst; M Forsgren; C Orvell; A Nemeth
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-07       Impact factor: 2.839

View more
  18 in total

1.  Expansion of prominin-1-expressing cells in association with fibrosis of biliary atresia.

Authors:  Nirmala Mavila; David James; Pranavkumar Shivakumar; Marie V Nguyen; Sarah Utley; Katrina Mak; Allison Wu; Shengmei Zhou; Larry Wang; Christopher Vendyres; Megan Groff; Kinji Asahina; Kasper S Wang
Journal:  Hepatology       Date:  2014-07-17       Impact factor: 17.425

2.  Vesicle-Cloaked Virus Clusters Are Optimal Units for Inter-organismal Viral Transmission.

Authors:  Marianita Santiana; Sourish Ghosh; Brian A Ho; Vignesh Rajasekaran; Wen-Li Du; Yael Mutsafi; Dennise A De Jésus-Diaz; Stanislav V Sosnovtsev; Eric A Levenson; Gabriel I Parra; Peter M Takvorian; Ann Cali; Christopher Bleck; Anastasia N Vlasova; Linda J Saif; John T Patton; Patrizia Lopalco; Angela Corcelli; Kim Y Green; Nihal Altan-Bonnet
Journal:  Cell Host Microbe       Date:  2018-08-08       Impact factor: 21.023

3.  Regulation of bile duct epithelial injury by hepatic CD71+ erythroid cells.

Authors:  Li Yang; Pranavkumar Shivakumar; Jeremy Kinder; Sing Sing Way; Bryan Donnelly; Reena Mourya; Zhenhua Luo; Jorge A Bezerra
Journal:  JCI Insight       Date:  2020-06-04

4.  Rhesus rotavirus VP4 sequence-specific activation of mononuclear cells is associated with cholangiopathy in murine biliary atresia.

Authors:  Ashley Walther; Sujit K Mohanty; Bryan Donnelly; Abigail Coots; Celine S Lages; Inna Lobeck; Phylicia Dupree; Jaroslaw Meller; Monica McNeal; Karol Sestak; Greg Tiao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-23       Impact factor: 4.052

5.  Prominin-1 Promotes Biliary Fibrosis Associated With Biliary Atresia.

Authors:  Jessica A Zagory; Michael Fenlon; William Dietz; Menghan Zhao; Marie V Nguyen; Pavin Trinh; Maeva Adoumie; Alex Park; Jiabo Xu; Elaa Mahdi; Alison Glazier; Nicolas Malkoff; Nirmala Mavila; Kasper S Wang
Journal:  Hepatology       Date:  2019-04-11       Impact factor: 17.425

6.  Rhesus rotavirus VP6 regulates ERK-dependent calcium influx in cholangiocytes.

Authors:  Inna Lobeck; Bryan Donnelly; Phylicia Dupree; Maxime M Mahe; Monica McNeal; Sujit K Mohanty; Greg Tiao
Journal:  Virology       Date:  2016-09-23       Impact factor: 3.616

7.  Role of myeloid differentiation factor 88 in Rhesus rotavirus-induced biliary atresia.

Authors:  Ashley E Walther; Sujit K Mohanty; Bryan Donnelly; Abigail Coots; Monica McNeal; Gregory M Tiao
Journal:  J Surg Res       Date:  2013-06-01       Impact factor: 2.192

8.  A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice.

Authors:  Ming Fu; Zefeng Lin; Huiting Lin; Yanlu Tong; Hezhen Wang; Hongjiao Chen; Yan Chen; Ruizhong Zhang
Journal:  J Vis Exp       Date:  2018-10-13       Impact factor: 1.355

9.  Functional and structural features of cholangiocytes in health and disease.

Authors:  Luca Maroni; Bai Haibo; Debolina Ray; Tianhao Zhou; Ying Wan; Fanyin Meng; Marco Marzioni; Gianfranco Alpini
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-07-01

10.  Rotavirus Infects Human Biliary Epithelial Cells and Stimulates Secretion of Cytokines IL-6 and IL-8 via MAPK Pathway.

Authors:  Maria Grazia Clemente; John T Patton; Robert A Anders; Robert H Yolken; Kathleen B Schwarz
Journal:  Biomed Res Int       Date:  2015-07-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.